Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK.
| Revenue (Most Recent Fiscal Year) | $255.87M |
| Net Income (Most Recent Fiscal Year) | $-103.26M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 3.78 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.65 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -39.99% |
| Net Margin (Trailing 12 Months) | -40.37% |
| Return on Equity (Trailing 12 Months) | -29.47% |
| Return on Assets (Trailing 12 Months) | -14.69% |
| Current Ratio (Most Recent Fiscal Quarter) | 2.75 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.75 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $4.94 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.44 |
| Earnings per Share (Most Recent Fiscal Year) | $-1.41 |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.42 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Common Shares Outstanding | 73.67M |
| Free Float | 58.20M |
| Market Capitalization | $966.48M |
| Average Volume (Last 20 Days) | 1.70M |
| Beta (Past 60 Months) | 1.57 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 21.00% |
| Percentage Held By Institutions (Latest 13F Reports) | 79.05% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |